Researchers at Harvard University’s Wyss Institute for Biologically Inspired Engineering have discovered a potential ...

No new treatments for schizophrenia have been approved in nearly three decades ... The company is currently studying the drug in Alzheimer’s-related psychosis, and next year plans to start late-stage ...

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

Eisai (ESAIY) completes BLA submissions for an injectable version of its Biogen (BIIB)-partered Alzheimer's drug Leqembi in ...

Approved by the FDA in July to treat adults with early symptomatic Alzheimer’s disease, Eli Lilly’s Kisunla reduced the brain ...

Geroscience has a long way to go, but there are four FDA-approved drugs that have shown promise to “target the process of ...

The Alzheimer's Association says more than 122,000 Missourians 65 years and older are battling Alzheimer's Disease, which has ...

Donanemab can slow the progression of Alzheimer’s disease. But what is the drug and how does it work? Here your questions on ...

Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients ...

If approved, the less burdensome version of Leqembi could be used to treat patients at home or in medical facilities, help ...

Find out what AI has already brought to Alzheimer's disease research and most importantly, what it can accomplish in the ...

With new therapies available to treat early stages of Alzheimer disease, recognizing the symptoms earlier is increasingly important.